Tag Archives: preemption

false advertising claim based on (c) ownership not preempted, court rules

Posted on June 14, 2017 by

Carter v. Pallante, 2017 WL 2506419, No. 16 C 6786 (N.D. Ill. Jun. 9, 2017) Tollie Carter has sued Maria A. Pallante (now acting Register Karyn Temple Claggett) in her capacity as the Register of Copyrights, as well as ARC/Conrad … Continue reading →

Posted in Uncategorized | Tagged , , , , , | Leave a comment

“unapproved drug” claims fail post-Pom, but not challenge to “natural” claim

Posted on June 12, 2017 by

Hi-Tech Pharmaceuticals, Inc. v. Hodges Consulting, Inc., 2016 WL 8856671, No. 16-cv-00906 (N.D. Ga. Dec. 13, 2016) Hi-Tech and Hodges compete in the dietary supplement market for body builders.  Hi-Tech sued for patent infringement, as well as for false advertising. … Continue reading →

Posted in Uncategorized | Tagged , , , | Leave a comment

New piece on the right of publicity and its limits

Posted on June 10, 2017 by

Rebecca Tushnet, Raising Walls Against Overlapping Rights: Preemption and the Right of Publicity, 92 NOTRE DAME L. REV. 1549 (2017). from Blogger http://ift.tt/2s6h652

Posted in Uncategorized | Tagged , , , , | Leave a comment

Dastar bars TM claim based on unlicensed copying of footage

Posted on April 24, 2017 by

Fioranelli v. CBS Broadcasting Inc., No. 15-CV-952, 2017 WL 1400119, — F. Supp. 3d – (S.D.N.Y.  Jan. 19, 2017) Fioranelli, a photojournalist who was one of four reporters allowed to enter the World Trade Center site on September 11, 2001, … Continue reading →

Posted in Uncategorized | Tagged , , , | Leave a comment

Copyright preemption and the right of publicity in the 9th Circuit

Posted on April 6, 2017 by

Maloney v. T3Media, Inc., No.15-55630 (9th Cir. Apr. 5, 2017) Welp, the Ninth Circuit manages to gum things up again in the right of publicity/copyright intersection.  To the extent that, post-Reed, the right of publicity has to survive strict scrutiny … Continue reading →

Posted in Uncategorized | Tagged , , | Leave a comment

Dastar/preemption bars claims based on allegedly false claims of credit for innovation

Posted on March 24, 2017 by

OptoLum, Inc. v. Cree, Inc., No. CV-16-03828, 2017 WL 1057924 (D. Ariz. Mar. 21, 2017) The parties compete in the market for LED lights. OptoLum claims to be the inventor of technology used inside LED bulbs allowing them to have … Continue reading →

Posted in Uncategorized | Tagged , , , | Leave a comment

allegedly false generic claims not actionable, but contributory liability possible

Posted on March 20, 2017 by

Concordia Pharm. Inc., S.À.R.L. v. Winder Laboratories, LLC, 16-CV-00004 (N.D. Ga. Mar. 15, 2017) Concordia makes Donnatal to treat irritable bowel syndrome and acute enterocolitis.  (There’s related litigation that ended badly for the defendant there.)  Concordia’s predecessor had conditional approval … Continue reading →

Posted in Uncategorized | Tagged , , , , , , | Leave a comment